nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—MPO—Carboplatin—brain cancer	0.435	0.652	CbGbCtD
Aminosalicylic Acid—PTGS2—Etoposide—brain cancer	0.126	0.189	CbGbCtD
Aminosalicylic Acid—PTGS1—Etoposide—brain cancer	0.107	0.16	CbGbCtD
Aminosalicylic Acid—Pericarditis—Procarbazine—brain cancer	0.00743	0.0585	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Procarbazine—brain cancer	0.00523	0.0411	CcSEcCtD
Aminosalicylic Acid—Eruption—Hydroxyurea—brain cancer	0.00404	0.0318	CcSEcCtD
Aminosalicylic Acid—MPO—endothelium—brain cancer	0.00369	0.0835	CbGeAlD
Aminosalicylic Acid—MPO—blood vessel—brain cancer	0.00341	0.077	CbGeAlD
Aminosalicylic Acid—Encephalopathy—Carmustine—brain cancer	0.00313	0.0246	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Procarbazine—brain cancer	0.00261	0.0205	CcSEcCtD
Aminosalicylic Acid—Haemolytic anaemia—Procarbazine—brain cancer	0.00258	0.0203	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Etoposide—brain cancer	0.00253	0.0199	CcSEcCtD
Aminosalicylic Acid—Purpura—Procarbazine—brain cancer	0.00242	0.019	CcSEcCtD
Aminosalicylic Acid—CHUK—endocrine gland—brain cancer	0.00219	0.0494	CbGeAlD
Aminosalicylic Acid—CHUK—head—brain cancer	0.00216	0.0488	CbGeAlD
Aminosalicylic Acid—PTGS1—ganglion—brain cancer	0.00203	0.046	CbGeAlD
Aminosalicylic Acid—Leukopenia—Lomustine—brain cancer	0.00198	0.0156	CcSEcCtD
Aminosalicylic Acid—CHUK—cerebellum—brain cancer	0.00193	0.0436	CbGeAlD
Aminosalicylic Acid—Thrombocytopenia—Lomustine—brain cancer	0.00177	0.0139	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Procarbazine—brain cancer	0.00176	0.0139	CcSEcCtD
Aminosalicylic Acid—PTGS1—endothelium—brain cancer	0.00175	0.0396	CbGeAlD
Aminosalicylic Acid—Jaundice—Procarbazine—brain cancer	0.00175	0.0138	CcSEcCtD
Aminosalicylic Acid—Anorexia—Lomustine—brain cancer	0.00172	0.0135	CcSEcCtD
Aminosalicylic Acid—PTGS2—endothelium—brain cancer	0.00168	0.0379	CbGeAlD
Aminosalicylic Acid—Body temperature increased—Carboplatin—brain cancer	0.00163	0.0128	CcSEcCtD
Aminosalicylic Acid—PTGS1—blood vessel—brain cancer	0.00162	0.0365	CbGeAlD
Aminosalicylic Acid—Vascular purpura—Temozolomide—brain cancer	0.00158	0.0124	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Lomustine—brain cancer	0.00157	0.0124	CcSEcCtD
Aminosalicylic Acid—CHUK—brain—brain cancer	0.00156	0.0354	CbGeAlD
Aminosalicylic Acid—PTGS2—blood vessel—brain cancer	0.00155	0.0349	CbGeAlD
Aminosalicylic Acid—Dermatitis exfoliative—Temozolomide—brain cancer	0.0015	0.0118	CcSEcCtD
Aminosalicylic Acid—Purpura—Temozolomide—brain cancer	0.00146	0.0115	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.00146	0.0115	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Lomustine—brain cancer	0.00143	0.0112	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00136	0.0107	CcSEcCtD
Aminosalicylic Acid—MPO—pituitary gland—brain cancer	0.00135	0.0304	CbGeAlD
Aminosalicylic Acid—Anaemia—Procarbazine—brain cancer	0.0013	0.0102	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Procarbazine—brain cancer	0.00126	0.00989	CcSEcCtD
Aminosalicylic Acid—ALOX5—endocrine gland—brain cancer	0.00123	0.0279	CbGeAlD
Aminosalicylic Acid—Abdominal distension—Temozolomide—brain cancer	0.00123	0.00966	CcSEcCtD
Aminosalicylic Acid—ALOX5—head—brain cancer	0.00122	0.0275	CbGeAlD
Aminosalicylic Acid—MPO—spinal cord—brain cancer	0.00116	0.0262	CbGeAlD
Aminosalicylic Acid—Vomiting—Lomustine—brain cancer	0.00115	0.00903	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Procarbazine—brain cancer	0.00112	0.00883	CcSEcCtD
Aminosalicylic Acid—ALOX5—central nervous system—brain cancer	0.00111	0.0251	CbGeAlD
Aminosalicylic Acid—Weight decreased—Temozolomide—brain cancer	0.0011	0.00868	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Carmustine—brain cancer	0.0011	0.00867	CcSEcCtD
Aminosalicylic Acid—Anorexia—Procarbazine—brain cancer	0.00109	0.0086	CcSEcCtD
Aminosalicylic Acid—ALOX5—cerebellum—brain cancer	0.00109	0.0245	CbGeAlD
Aminosalicylic Acid—Nausea—Lomustine—brain cancer	0.00107	0.00844	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Temozolomide—brain cancer	0.00107	0.00838	CcSEcCtD
Aminosalicylic Acid—MPO—endocrine gland—brain cancer	0.00104	0.0236	CbGeAlD
Aminosalicylic Acid—MPO—head—brain cancer	0.00103	0.0233	CbGeAlD
Aminosalicylic Acid—Anaemia—Hydroxyurea—brain cancer	0.00101	0.00791	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Procarbazine—brain cancer	0.000997	0.00784	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Temozolomide—brain cancer	0.000976	0.00768	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Hydroxyurea—brain cancer	0.000973	0.00766	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Temozolomide—brain cancer	0.000964	0.00758	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Temozolomide—brain cancer	0.000957	0.00753	CcSEcCtD
Aminosalicylic Acid—MPO—central nervous system—brain cancer	0.00094	0.0212	CbGeAlD
Aminosalicylic Acid—Gastrointestinal pain—Procarbazine—brain cancer	0.000938	0.00738	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00092	0.00723	CcSEcCtD
Aminosalicylic Acid—Urticaria—Procarbazine—brain cancer	0.000911	0.00717	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Procarbazine—brain cancer	0.000907	0.00713	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Procarbazine—brain cancer	0.000907	0.00713	CcSEcCtD
Aminosalicylic Acid—ALOX5—brain—brain cancer	0.000882	0.0199	CbGeAlD
Aminosalicylic Acid—Malnutrition—Carmustine—brain cancer	0.000879	0.00692	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Hydroxyurea—brain cancer	0.00087	0.00685	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Hydroxyurea—brain cancer	0.000869	0.00684	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Hydroxyurea—brain cancer	0.000862	0.00678	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Etoposide—brain cancer	0.000853	0.00671	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Temozolomide—brain cancer	0.00085	0.00668	CcSEcCtD
Aminosalicylic Acid—Jaundice—Etoposide—brain cancer	0.000848	0.00667	CcSEcCtD
Aminosalicylic Acid—Anorexia—Hydroxyurea—brain cancer	0.000846	0.00665	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Procarbazine—brain cancer	0.000845	0.00665	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Temozolomide—brain cancer	0.000832	0.00654	CcSEcCtD
Aminosalicylic Acid—Anaemia—Carmustine—brain cancer	0.000813	0.00639	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Etoposide—brain cancer	0.000812	0.00639	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Carmustine—brain cancer	0.000787	0.00619	CcSEcCtD
Aminosalicylic Acid—Anaemia—Temozolomide—brain cancer	0.000785	0.00618	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Procarbazine—brain cancer	0.000785	0.00617	CcSEcCtD
Aminosalicylic Acid—PTGS1—telencephalon—brain cancer	0.000784	0.0177	CbGeAlD
Aminosalicylic Acid—Decreased appetite—Hydroxyurea—brain cancer	0.000772	0.00607	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Etoposide—brain cancer	0.000771	0.00607	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000766	0.00603	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Etoposide—brain cancer	0.000766	0.00602	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Temozolomide—brain cancer	0.00076	0.00598	CcSEcCtD
Aminosalicylic Acid—Dizziness—Procarbazine—brain cancer	0.000758	0.00597	CcSEcCtD
Aminosalicylic Acid—PTGS2—telencephalon—brain cancer	0.00075	0.0169	CbGeAlD
Aminosalicylic Acid—MPO—brain—brain cancer	0.000746	0.0169	CbGeAlD
Aminosalicylic Acid—Vomiting—Procarbazine—brain cancer	0.000729	0.00574	CcSEcCtD
Aminosalicylic Acid—Rash—Procarbazine—brain cancer	0.000723	0.00569	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Procarbazine—brain cancer	0.000722	0.00568	CcSEcCtD
Aminosalicylic Acid—Headache—Procarbazine—brain cancer	0.000718	0.00565	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000718	0.00565	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Carmustine—brain cancer	0.000703	0.00553	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Hydroxyurea—brain cancer	0.000702	0.00552	CcSEcCtD
Aminosalicylic Acid—Anorexia—Carmustine—brain cancer	0.000684	0.00538	CcSEcCtD
Aminosalicylic Acid—Nausea—Procarbazine—brain cancer	0.000681	0.00536	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Temozolomide—brain cancer	0.00068	0.00535	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Temozolomide—brain cancer	0.000679	0.00534	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Temozolomide—brain cancer	0.000674	0.0053	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Etoposide—brain cancer	0.000666	0.00524	CcSEcCtD
Aminosalicylic Acid—Anorexia—Temozolomide—brain cancer	0.000661	0.0052	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Hydroxyurea—brain cancer	0.000654	0.00514	CcSEcCtD
Aminosalicylic Acid—PTGS1—pituitary gland—brain cancer	0.000638	0.0144	CbGeAlD
Aminosalicylic Acid—Anaemia—Etoposide—brain cancer	0.000628	0.00494	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Carmustine—brain cancer	0.000624	0.00491	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Carmustine—brain cancer	0.000619	0.00487	CcSEcCtD
Aminosalicylic Acid—PTGS2—pituitary gland—brain cancer	0.00061	0.0138	CbGeAlD
Aminosalicylic Acid—Leukopenia—Etoposide—brain cancer	0.000609	0.00479	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Hydroxyurea—brain cancer	0.000607	0.00478	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Temozolomide—brain cancer	0.000603	0.00474	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Temozolomide—brain cancer	0.000599	0.00471	CcSEcCtD
Aminosalicylic Acid—PTGS2—medulla oblongata—brain cancer	0.000589	0.0133	CbGeAlD
Aminosalicylic Acid—Dizziness—Hydroxyurea—brain cancer	0.000587	0.00462	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Carmustine—brain cancer	0.000587	0.00462	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000575	0.00452	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Carmustine—brain cancer	0.000567	0.00446	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Carmustine—brain cancer	0.000567	0.00446	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Temozolomide—brain cancer	0.000567	0.00446	CcSEcCtD
Aminosalicylic Acid—Vomiting—Hydroxyurea—brain cancer	0.000564	0.00444	CcSEcCtD
Aminosalicylic Acid—Rash—Hydroxyurea—brain cancer	0.00056	0.0044	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Hydroxyurea—brain cancer	0.000559	0.0044	CcSEcCtD
Aminosalicylic Acid—Headache—Hydroxyurea—brain cancer	0.000556	0.00437	CcSEcCtD
Aminosalicylic Acid—Urticaria—Temozolomide—brain cancer	0.000551	0.00433	CcSEcCtD
Aminosalicylic Acid—PTGS1—spinal cord—brain cancer	0.000549	0.0124	CbGeAlD
Aminosalicylic Acid—Body temperature increased—Temozolomide—brain cancer	0.000548	0.00431	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Temozolomide—brain cancer	0.000548	0.00431	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Etoposide—brain cancer	0.000543	0.00427	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Etoposide—brain cancer	0.000539	0.00424	CcSEcCtD
Aminosalicylic Acid—PTGS2—midbrain—brain cancer	0.000538	0.0122	CbGeAlD
Aminosalicylic Acid—Anorexia—Etoposide—brain cancer	0.000529	0.00416	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Carmustine—brain cancer	0.000529	0.00416	CcSEcCtD
Aminosalicylic Acid—Nausea—Hydroxyurea—brain cancer	0.000527	0.00415	CcSEcCtD
Aminosalicylic Acid—PTGS2—spinal cord—brain cancer	0.000525	0.0119	CbGeAlD
Aminosalicylic Acid—Hypersensitivity—Temozolomide—brain cancer	0.000511	0.00402	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—CYP2C9—brain cancer	0.000509	1	CrCbGaD
Aminosalicylic Acid—PTGS1—endocrine gland—brain cancer	0.000495	0.0112	CbGeAlD
Aminosalicylic Acid—Diarrhoea—Carmustine—brain cancer	0.000491	0.00386	CcSEcCtD
Aminosalicylic Acid—PTGS1—head—brain cancer	0.000488	0.011	CbGeAlD
Aminosalicylic Acid—Decreased appetite—Etoposide—brain cancer	0.000482	0.00379	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Etoposide—brain cancer	0.000479	0.00377	CcSEcCtD
Aminosalicylic Acid—Dizziness—Carmustine—brain cancer	0.000474	0.00373	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Temozolomide—brain cancer	0.000474	0.00373	CcSEcCtD
Aminosalicylic Acid—PTGS2—endocrine gland—brain cancer	0.000473	0.0107	CbGeAlD
Aminosalicylic Acid—PTGS2—head—brain cancer	0.000467	0.0106	CbGeAlD
Aminosalicylic Acid—Dizziness—Temozolomide—brain cancer	0.000459	0.00361	CcSEcCtD
Aminosalicylic Acid—Vomiting—Carmustine—brain cancer	0.000456	0.00359	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Etoposide—brain cancer	0.000454	0.00357	CcSEcCtD
Aminosalicylic Acid—Rash—Carmustine—brain cancer	0.000452	0.00356	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Carmustine—brain cancer	0.000452	0.00356	CcSEcCtD
Aminosalicylic Acid—Headache—Carmustine—brain cancer	0.000449	0.00354	CcSEcCtD
Aminosalicylic Acid—PTGS1—central nervous system—brain cancer	0.000446	0.0101	CbGeAlD
Aminosalicylic Acid—Vomiting—Temozolomide—brain cancer	0.000441	0.00347	CcSEcCtD
Aminosalicylic Acid—Urticaria—Etoposide—brain cancer	0.000441	0.00347	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Etoposide—brain cancer	0.000439	0.00345	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Etoposide—brain cancer	0.000439	0.00345	CcSEcCtD
Aminosalicylic Acid—Rash—Temozolomide—brain cancer	0.000437	0.00344	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Temozolomide—brain cancer	0.000437	0.00344	CcSEcCtD
Aminosalicylic Acid—Headache—Temozolomide—brain cancer	0.000434	0.00342	CcSEcCtD
Aminosalicylic Acid—Nausea—Carmustine—brain cancer	0.000426	0.00335	CcSEcCtD
Aminosalicylic Acid—PTGS2—central nervous system—brain cancer	0.000426	0.00963	CbGeAlD
Aminosalicylic Acid—PTGS2—cerebellum—brain cancer	0.000416	0.00941	CbGeAlD
Aminosalicylic Acid—Nausea—Temozolomide—brain cancer	0.000412	0.00324	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Etoposide—brain cancer	0.000409	0.00322	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Etoposide—brain cancer	0.00038	0.00299	CcSEcCtD
Aminosalicylic Acid—Dizziness—Etoposide—brain cancer	0.000367	0.00289	CcSEcCtD
Aminosalicylic Acid—PTGS1—brain—brain cancer	0.000354	0.008	CbGeAlD
Aminosalicylic Acid—Vomiting—Etoposide—brain cancer	0.000353	0.00277	CcSEcCtD
Aminosalicylic Acid—Rash—Etoposide—brain cancer	0.00035	0.00275	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Etoposide—brain cancer	0.00035	0.00275	CcSEcCtD
Aminosalicylic Acid—Headache—Etoposide—brain cancer	0.000348	0.00273	CcSEcCtD
Aminosalicylic Acid—PTGS2—brain—brain cancer	0.000338	0.00765	CbGeAlD
Aminosalicylic Acid—Nausea—Etoposide—brain cancer	0.00033	0.00259	CcSEcCtD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—APC—brain cancer	0.000261	0.00163	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—ERBB2—brain cancer	0.000261	0.00163	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Leptin signaling pathway—STAT3—brain cancer	0.00026	0.00162	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—EGFR—brain cancer	0.000259	0.00162	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—DTX2—brain cancer	0.000258	0.00161	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—RELA—brain cancer	0.000256	0.0016	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000256	0.0016	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000255	0.00159	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—brain cancer	0.000253	0.00158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—PDGFRA—brain cancer	0.000252	0.00158	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CYP2C9—brain cancer	0.000251	0.00157	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—IRS2—brain cancer	0.00025	0.00156	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—IRS2—brain cancer	0.00025	0.00156	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—IRS2—brain cancer	0.00025	0.00156	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—IRS2—brain cancer	0.000248	0.00155	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—RELA—brain cancer	0.000247	0.00154	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—IRS2—brain cancer	0.000246	0.00154	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—IRS2—brain cancer	0.000245	0.00153	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000244	0.00153	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—VAV1—brain cancer	0.000241	0.00151	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—STAT3—brain cancer	0.000238	0.00148	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—VAV1—brain cancer	0.000237	0.00148	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—RELA—brain cancer	0.000233	0.00145	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—IRS2—brain cancer	0.000232	0.00145	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—IL2—brain cancer	0.000231	0.00144	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.00023	0.00144	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	0.000225	0.00141	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—IRS2—brain cancer	0.000222	0.00138	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000221	0.00138	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—MYC—brain cancer	0.000221	0.00138	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—brain cancer	0.000217	0.00136	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	0.000216	0.00135	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000215	0.00134	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—BSG—brain cancer	0.000213	0.00133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—OR14C36—brain cancer	0.000212	0.00133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—OR4C12—brain cancer	0.000212	0.00133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—p75(NTR)-mediated signaling—TP53—brain cancer	0.000212	0.00133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Constitutive PI3K/AKT Signaling in Cancer—EGFR—brain cancer	0.000212	0.00132	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000212	0.00132	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—RELA—brain cancer	0.00021	0.00131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000208	0.0013	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—RELA—brain cancer	0.000207	0.00129	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000207	0.00129	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—ERBB2—brain cancer	0.000206	0.00129	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—RELA—brain cancer	0.000204	0.00127	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—ERBB2—brain cancer	0.000197	0.00123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—MYC—brain cancer	0.000197	0.00123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—STAT3—brain cancer	0.000194	0.00121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—PDGFRA—brain cancer	0.000194	0.00121	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000194	0.00121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—ERBB2—brain cancer	0.000194	0.00121	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—CDKN2A—brain cancer	0.000193	0.00121	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—CDK4—brain cancer	0.000192	0.0012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI-3K cascade—EGFR—brain cancer	0.000191	0.00119	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HES5—brain cancer	0.000189	0.00118	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—EGFR—brain cancer	0.000186	0.00116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—ERBB2—brain cancer	0.000185	0.00116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—EGFR—brain cancer	0.000185	0.00115	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—ERBB2—brain cancer	0.000184	0.00115	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—IDH1—brain cancer	0.000184	0.00115	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—ERBB2—brain cancer	0.000183	0.00114	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—ERBB2—brain cancer	0.000182	0.00114	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—TP53—brain cancer	0.000181	0.00113	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—RELA—brain cancer	0.000181	0.00113	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—brain cancer	0.000181	0.00113	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—DTX2—brain cancer	0.000181	0.00113	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—brain cancer	0.00018	0.00112	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—RELA—brain cancer	0.000179	0.00112	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000179	0.00112	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—CTNNB1—brain cancer	0.000177	0.00111	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000176	0.0011	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IRS2—brain cancer	0.000173	0.00108	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000173	0.00108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—RELA—brain cancer	0.000173	0.00108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000172	0.00108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—ERBB2—brain cancer	0.000172	0.00107	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—ERBB2—brain cancer	0.000172	0.00107	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—ERBB2—brain cancer	0.000172	0.00107	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000171	0.00107	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.00017	0.00106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—IRS2—brain cancer	0.00017	0.00106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—SKP2—brain cancer	0.00017	0.00106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—ERBB2—brain cancer	0.00017	0.00106	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—PIK3CG—brain cancer	0.00017	0.00106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—ERBB2—brain cancer	0.000169	0.00105	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—ERBB2—brain cancer	0.000168	0.00105	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—CCND1—brain cancer	0.000163	0.00102	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000161	0.00101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—RELA—brain cancer	0.00016	0.000998	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000159	0.000992	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—ERBB2—brain cancer	0.000159	0.000992	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—STAT3—brain cancer	0.000157	0.00098	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—STAT3—brain cancer	0.000154	0.000964	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—DTX2—brain cancer	0.000153	0.000954	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—ERBB2—brain cancer	0.000152	0.000949	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000151	0.000945	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.00015	0.000937	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000149	0.000933	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ENO2—brain cancer	0.000145	0.000906	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—EGFR—brain cancer	0.000143	0.000891	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000143	0.000891	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000142	0.000886	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000141	0.000882	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—STAT3—brain cancer	0.000141	0.000882	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000138	0.000862	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTCH2—brain cancer	0.000137	0.000855	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—EGFR—brain cancer	0.000137	0.000853	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—VAV1—brain cancer	0.000135	0.000845	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000135	0.000844	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—EGFR—brain cancer	0.000134	0.000839	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HES5—brain cancer	0.000133	0.000828	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—STAT3—brain cancer	0.000131	0.000817	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000131	0.000817	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—MYC—brain cancer	0.000131	0.000817	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—VAV1—brain cancer	0.00013	0.000811	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—STRADA—brain cancer	0.000129	0.000803	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—EGFR—brain cancer	0.000128	0.000801	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—STAT3—brain cancer	0.000128	0.000799	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—EGFR—brain cancer	0.000128	0.000797	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL2—brain cancer	0.000127	0.000796	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IDH1—brain cancer	0.000127	0.000795	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—EGFR—brain cancer	0.000127	0.000793	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—EGFR—brain cancer	0.000126	0.00079	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—EGFR—brain cancer	0.000125	0.000778	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000124	0.000777	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—CCND1—brain cancer	0.000124	0.000776	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000123	0.000769	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HEY1—brain cancer	0.000121	0.000754	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—RELA—brain cancer	0.00012	0.000747	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—EGFR—brain cancer	0.000119	0.000743	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—EGFR—brain cancer	0.000119	0.000743	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—EGFR—brain cancer	0.000119	0.000743	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—DLL1—brain cancer	0.000118	0.000739	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—EGFR—brain cancer	0.000118	0.000736	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—RELA—brain cancer	0.000118	0.000735	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—ERBB2—brain cancer	0.000117	0.00073	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—EGFR—brain cancer	0.000117	0.00073	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—EGFR—brain cancer	0.000116	0.000726	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—STAT3—brain cancer	0.000116	0.000724	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000114	0.000715	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—TP53—brain cancer	0.000113	0.000708	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HES5—brain cancer	0.000112	0.0007	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000112	0.000699	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PDGFRA—brain cancer	0.000111	0.000692	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—EGFR—brain cancer	0.00011	0.000687	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP2C9—brain cancer	0.000109	0.00068	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL2—brain cancer	0.000108	0.000673	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ABR—brain cancer	0.000107	0.000671	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PDGFRA—brain cancer	0.000106	0.000664	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—EGFR—brain cancer	0.000105	0.000658	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GLI2—brain cancer	0.000104	0.000648	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—SKP2—brain cancer	0.000103	0.000645	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ENO2—brain cancer	0.000101	0.000629	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SHH—brain cancer	0.000101	0.000629	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—MYC—brain cancer	9.96e-05	0.000622	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GLI1—brain cancer	9.75e-05	0.000609	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—EGFR—brain cancer	9.74e-05	0.000609	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IRS2—brain cancer	9.72e-05	0.000607	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	9.56e-05	0.000597	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	9.4e-05	0.000587	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—IRS2—brain cancer	9.34e-05	0.000583	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—BSG—brain cancer	9.25e-05	0.000578	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SUFU—brain cancer	9.24e-05	0.000577	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—STAT3—brain cancer	9.07e-05	0.000566	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GFAP—brain cancer	8.92e-05	0.000557	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—STAT3—brain cancer	8.91e-05	0.000557	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP2C9—brain cancer	8.64e-05	0.00054	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HEY1—brain cancer	8.45e-05	0.000528	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	8.45e-05	0.000528	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	8.37e-05	0.000523	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—DLL1—brain cancer	8.29e-05	0.000518	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TP53—brain cancer	8.18e-05	0.000511	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—EGFR—brain cancer	8.1e-05	0.000506	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—IDH1—brain cancer	7.96e-05	0.000497	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—VAV1—brain cancer	7.88e-05	0.000492	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IDH1—brain cancer	7.54e-05	0.000471	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	7.37e-05	0.00046	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—BSG—brain cancer	7.35e-05	0.000459	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—VAV1—brain cancer	7.27e-05	0.000454	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HEY1—brain cancer	7.15e-05	0.000447	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SHH—brain cancer	7.05e-05	0.00044	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—DLL1—brain cancer	7.01e-05	0.000438	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TRPC6—brain cancer	6.8e-05	0.000424	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	6.78e-05	0.000423	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—RELA—brain cancer	6.71e-05	0.000419	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTCH1—brain cancer	6.68e-05	0.000417	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SMO—brain cancer	6.68e-05	0.000417	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—ERBB2—brain cancer	6.67e-05	0.000416	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CG—brain cancer	6.65e-05	0.000416	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	6.63e-05	0.000414	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.48e-05	0.000405	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PDGFRA—brain cancer	6.45e-05	0.000403	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—RELA—brain cancer	6.44e-05	0.000402	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—ERBB2—brain cancer	6.4e-05	0.0004	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—IDH1—brain cancer	6.32e-05	0.000395	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ENO2—brain cancer	6.29e-05	0.000393	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HES1—brain cancer	6.25e-05	0.000391	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SHH—brain cancer	5.96e-05	0.000372	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ENO2—brain cancer	5.96e-05	0.000372	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PDGFRA—brain cancer	5.95e-05	0.000372	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CTNNB1—brain cancer	5.83e-05	0.000364	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IRS2—brain cancer	5.66e-05	0.000354	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	5.57e-05	0.000348	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOTCH2—brain cancer	5.34e-05	0.000334	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IRS2—brain cancer	5.23e-05	0.000327	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.14e-05	0.000321	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VAV1—brain cancer	5.09e-05	0.000318	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ENO2—brain cancer	4.99e-05	0.000312	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—EGFR—brain cancer	4.62e-05	0.000289	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APC—brain cancer	4.62e-05	0.000288	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—EGFR—brain cancer	4.44e-05	0.000277	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HES1—brain cancer	4.38e-05	0.000274	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—VAV1—brain cancer	4.31e-05	0.000269	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PDGFRA—brain cancer	4.17e-05	0.00026	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SPP1—brain cancer	4.05e-05	0.000253	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—RELA—brain cancer	3.91e-05	0.000244	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ERBB2—brain cancer	3.88e-05	0.000243	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HES1—brain cancer	3.7e-05	0.000231	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IRS2—brain cancer	3.66e-05	0.000229	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ERBB2—brain cancer	3.59e-05	0.000224	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PDGFRA—brain cancer	3.53e-05	0.00022	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL2—brain cancer	3.52e-05	0.00022	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CTNNB1—brain cancer	3.4e-05	0.000212	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APC—brain cancer	3.23e-05	0.000202	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CG—brain cancer	3.23e-05	0.000202	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CTNNB1—brain cancer	3.14e-05	0.000196	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IRS2—brain cancer	3.1e-05	0.000193	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—STAT3—brain cancer	2.96e-05	0.000185	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CG—brain cancer	2.89e-05	0.00018	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APC—brain cancer	2.74e-05	0.000171	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—STAT3—brain cancer	2.73e-05	0.000171	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EGFR—brain cancer	2.69e-05	0.000168	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MYC—brain cancer	2.54e-05	0.000159	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RELA—brain cancer	2.53e-05	0.000158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ERBB2—brain cancer	2.51e-05	0.000157	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EGFR—brain cancer	2.49e-05	0.000155	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CG—brain cancer	2.29e-05	0.000143	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2—brain cancer	2.28e-05	0.000142	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCND1—brain cancer	2.22e-05	0.000139	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CTNNB1—brain cancer	2.2e-05	0.000137	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ERBB2—brain cancer	2.12e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—brain cancer	1.93e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—STAT3—brain cancer	1.91e-05	0.00012	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CTNNB1—brain cancer	1.86e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MYC—brain cancer	1.78e-05	0.000111	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EGFR—brain cancer	1.74e-05	0.000109	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—STAT3—brain cancer	1.62e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MYC—brain cancer	1.5e-05	9.4e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EGFR—brain cancer	1.47e-05	9.19e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—brain cancer	1.46e-05	9.13e-05	CbGpPWpGaD
